John Pernow Swedish physician
Pernow, John
Pernow, John, 1960-
VIAF ID: 219674153 (Personal)
Permalink: http://viaf.org/viaf/219674153
Preferred Forms
- 100 0 _ ‡a John Pernow ‡c Swedish physician
-
- 100 1 _ ‡a Pernow, John
-
-
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control | |
Limitation of infarct size and attenuation of myeloperoxidase activity by an endothelin A receptor antagonist following ischaemia and reperfusion | |
Lipid lowering versus pleiotropic effects of statins on skin microvascular function in patients with dysglycaemia and coronary artery disease | |
Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production | |
Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction | |
Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors | |
Multibiomarker analysis in patients with acute myocardial infarction. | |
Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice | |
Myocardial protection by co-administration of L-arginine and tetrahydrobiopterin during ischemia and reperfusion | |
Myocardial release of endothelin (ET) and enhanced ET(A) receptor-mediated coronary vasoconstriction after coronary thrombosis and thrombolysis in pigs | |
Neuropeptide Y induces potent contraction of arterial vascular smooth muscle via an endothelium-independent mechanism | |
Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumors and plasma of pheochromocytoma patients | |
Neuropeptide Y release from human heart is enhanced during prolonged exercise in hypoxia | |
Neuropeptide Y-, substance P- and VIP-immunoreactive nerves in cat spleen in relation to autonomic vascular and volume control. | |
New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus | |
No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation | |
No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance | |
The nonpeptide endothelin receptor antagonist bosentan enhances myocardial recovery and endothelial function during reperfusion of the ischemic rat heart | |
Noradrenaline release evoked by a physiological irregular sympathetic discharge pattern is modulated by prejunctional alpha- and beta-adrenoceptors in vivo | |
NPY--a mediator of reserpine-resistant, non-adrenergic vasoconstriction in cat spleen after preganglionic denervation? | |
Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trial | |
PAR1-stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4-stimulated platelet releasate. | |
Pharmacological possibilities for protection against myocardial reperfusion injury | |
Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission | |
Phentolamine- and clonidine-induced changes in plasma neuropeptide Y-like immunoreactivity during sympathetic activation in man | |
Postexercise ischemia is associated with increased neuropeptide Y in patients with coronary artery disease | |
Potent selective vasoconstrictor effects of endothelin in the pig kidney in vivo. | |
Pre- and postjunctional effects of NPY on sympathetic control of rat femoral artery | |
Quantification of myocardium at risk in ST- elevation myocardial infarction: a comparison of contrast-enhanced steady-state free precession cine cardiovascular magnetic resonance with coronary angiographic jeopardy scores | |
A randomized clinical trial of the effects of leafy green vegetables and inorganic nitrate on blood pressure | |
Red blood cell dysfunction: a new player in cardiovascular disease | |
Red Blood Cells in Type 2 Diabetes Impair Cardiac Post-Ischemic Recovery Through an Arginase-Dependent Modulation of Nitric Oxide Synthase and Reactive Oxygen Species | |
Regional extraction of endothelins and conversion of big endothelin to endothelin-1 in the pig. | |
Regulation of glucose uptake by endothelin-1 in human skeletal muscle in vivo and in vitro | |
Relation of hypertriglyceridemia to plasma concentrations of biochemical markers of inflammation and endothelial activation (C-reactive protein, interleukin-6, soluble adhesion molecules, von Willebrand factor, and endothelin-1) | |
Release of endothelin-like immunoreactivity in relation to neuropeptide Y and catecholamines during endotoxin shock and asphyxia in the pig. | |
Release of vasoactive peptides from autonomic and sensory nerves | |
Remote ischaemic pre- and delayed postconditioning - similar degree of cardioprotection but distinct mechanisms | |
Repeated renal and splenic sympathetic nerve stimulation in anaesthetized pigs: maintained overflow of neuropeptide Y in controls but not after reserpine. | |
Reply: Glucagon-like peptide-1 mediates cardioprotection by remote ischaemic conditioning | |
Reply to comment by Elbadawi et al | |
Reply to letter to the editor by Lou et al | |
Resection of a giant left main stem coronary artery aneurysm. | |
The role of arginase and rho kinase in cardioprotection from remote ischemic perconditioning in non-diabetic and diabetic rat in vivo | |
The role of arginase in the microcirculation in cardiovascular disease | |
The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury | |
sabbu | |
Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease | |
Semi-automatic segmentation of myocardium at risk from contrast enhanced SSFP images - validation against manual delineation and SPECT | |
Short-acting calcium antagonist clevidipine protects against reperfusion injury via local nitric oxide-related mechanisms in the jeopardised myocardium. | |
Small skin burn injury reduces cardiac tolerance to ischemia via a tumor necrosis factor alpha-dependent pathway | |
Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk for cardiac events | |
Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y | |
Tetraspanin CD151 and integrin α6β1 mediate platelet-enhanced endothelial colony forming cell angiogenesis. | |
Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus | |
A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation | |
Uridine adenosine tetraphosphate acts as a proangiogenic factor in vitro through purinergic P2Y receptors. | |
Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update | |
Urotensin II evokes potent vasoconstriction in humans in vivo | |
Vagal nerve stimulation reduces infarct size via a mechanism involving the alpha-7 nicotinic acetylcholine receptor and downregulation of cardiac and vascular arginase | |
Vascular effects, formation, clearance and release of endothelin peptides in the pig. | |
Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man | |
Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivo |